Science Signaling
Data on Science Signaling Published by Researchers at Memorial Sloan-Kettering Cancer Center
Published in Drug Week, June 3rd, 2011
2011 JUN 3 -- New research, "Resistance to MEK inhibitors: should we co-target upstream," is the subject of a report. According to recent research published in the journal Science Signaling, "Aberrant activation of the ERK pathway is common in human tumors. This pathway consists of a three-tiered kinase module [comprising the kinases RAF, mitogen-activated protein kinase (MAPK) kinase (MEK), and extracellular signal-regulated kinase (ERK)] that functions as a negative feedback amplifier to confer robustness and stabilization of pathway output."
"Because this pathway is frequently dysregulated in human cancers, intense efforts are under way to develop...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-06-03)
More Articles from Drug Week
- Aromatic Amino Acids
Data on Aromatic Amino Acids Detailed by Researchers at University of California - Depression
Data on Depression Discussed by Researchers at University of Szeged - Pediatrics
Data on Pediatrics Published by C. Slidsborg and Colleagues - Phenethylamines
Data on Phenethylamines Reported by Researchers at University of Lethbridge - Metabolism
Findings from University of Liverpool Provide New Insights into Metabolism - Macromolecular Research
Findings in Macromolecular Research Reported from Sichuan University - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
